Back
Fonar Vs. OncoCyte Industry Stock Comparison
Sell
29
FONR
Fonar
Last Price:
$15.88
Seasonality Move:
0.57%
Sell
20
OCX
OncoCyte
Last Price:
$2.24
Seasonality Move:
16.26%
Sell
29
Fonar (FONR)
is a Sell
Is Fonar a Buy, Sell or Hold?
-
FONR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FONR Stock Price Chart
OCX Stock Price Chart
FONR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 41.17 | Sell |
Chaikin Money Flow: | 1061 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.17 - 16.27) | Sell |
Bollinger Bands (100): | (15.34 - 17.14) | Sell |
OCX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 30.62 | Sell |
Chaikin Money Flow: | -55338 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.3 - 2.64) | Sell |
Bollinger Bands (100): | (2.62 - 3.18) | Sell |
FONR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.43 | Sell |
20-day SMA: | 15.89 | Sell |
50-day SMA: | 15.53 | Sell |
200-day SMA: | 16.88 | Sell |
8-day EMA: | 15.42 | Sell |
20-day EMA: | 15.6 | Sell |
50-day EMA: | 15.76 | Sell |
200-day EMA: | 16.61 | Sell |
OCX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.31 | Sell |
20-day SMA: | 2.42 | Sell |
50-day SMA: | 2.75 | Sell |
200-day SMA: | 2.89 | Sell |
8-day EMA: | 2.29 | Sell |
20-day EMA: | 2.42 | Sell |
50-day EMA: | 2.64 | Sell |
200-day EMA: | 3.07 | Sell |
Fonar Earnings Growth & FONR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
OncoCyte Earnings Growth & OCX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.17 per share, and an increase next year of $0.68 per share.
Fonar Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
OncoCyte Technical Analysis
Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |